Ascentage Pharma Group International (AAPG) Accumulated Expenses (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Accumulated Expenses for 3 consecutive years, with $381949.0 as the latest value for Q4 2025.
- For Q4 2025, Accumulated Expenses fell 81.52% year-over-year to $381949.0; the TTM value through Dec 2025 reached $381949.0, down 81.52%, while the annual FY2025 figure was $387000.0, 80.97% down from the prior year.
- Accumulated Expenses hit $381949.0 in Q4 2025 for Ascentage Pharma Group International, down from $2.1 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $2.1 million in Q4 2024 and bottomed at $381949.0 in Q4 2025.
- Average Accumulated Expenses over 3 years is $1.0 million, with a median of $568049.4 recorded in 2023.
- Year-over-year, Accumulated Expenses skyrocketed 263.87% in 2024 and then crashed 81.52% in 2025.
- Ascentage Pharma Group International's Accumulated Expenses stood at $568049.4 in 2023, then surged by 263.87% to $2.1 million in 2024, then crashed by 81.52% to $381949.0 in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods came in at $381949.0, $2.1 million, and $568049.4 for Q4 2025, Q4 2024, and Q4 2023 respectively.